The HIV+Hepatitis Policy Institute is a national HIV and hepatitis policy organization promoting quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. We strongly support Senate Bill 560, which would require health insurers to accept and count payments made on behalf of patients for prescription drugs towards their deductible and out-of-pocket maximum.
read more
Letter to New Mexico state senators in support of copay accumulator ban bill (HB 129/a)
We strongly support House Bill 129/a, which would require health insurers and health care service contractors to accept and count payments made on behalf of patients towards deductibles and out-of-pocket maximums.
Support of Maryland House Bill 167 so that patients can afford their prescription medications
Comments on additional policy and regulatory revisions in response to the COVID-19 public health emergency
The HIV+Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious…
Comments on notice of benefit and payment parameters proposed for 2022 rule: CMS 9914-P
The HIV+Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions, is pleased to submit comments on the proposed Notice of Benefit and…